It not only has an obvious chemotaxis effect on immune cells, such as B lymphocytes, T lymphocytes, and neutrophils, but also participates in the TNFR2/BIRC3‐TRAF1 signaling pathway, that is a novel NK cell immune checkpoint for cancer.24 The gene discussed is TRAF1; the disease is cancer.